Please login to the form below

Not currently logged in
Email:
Password:

Revinty Ellipta

This page shows the latest Revinty Ellipta news and features for those working in and with pharma, biotech and healthcare.

Boehringer/Lilly's empagliflozin among CHMP recommendations

Boehringer/Lilly's empagliflozin among CHMP recommendations

Other positive opinions issued by the CHMP included Actavis' Ebilfumin, a generic version of Roche's flu drug Tamiflu (oseltamivir), and GlaxoSmithKline's Revinty Ellipta (fluticasone furoate and vilanterol) for the

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GEM Marketing Ltd

GEM, a small but perfectly formed integrated marketing agency servicing the pharmaceutical industry....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics